University Of Maryland, Baltimore
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Blood Donor CVD 9000
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 3
- Registration Number
- NCT03724357
- Locations
- 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
- Conditions
- Typhoid and/or Cholera Vaccination
- Interventions
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 240
- Registration Number
- NCT03705585
- Locations
- 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
- Conditions
- Hepatitis C
- Interventions
- Drug: Direct Acting Antivirals
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03702218
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
Neuromuscular and Biomechanical Control of Lower Limb Loading in Individuals With Chronic Stroke
- Conditions
- StrokeHemiparesis
- Interventions
- Other: Conventional TrainingOther: Limb Loading
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 25
- Registration Number
- NCT03694028
- Locations
- 🇺🇸
PTRS Research Lab, Baltimore, Maryland, United States
Nicotinamide Riboside for Diabetic Neuropathy
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 54
- Registration Number
- NCT03685253
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Phase I Nab-Paclitaxel Plus Gemcitabine with Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
- Conditions
- Locally Advanced Pancreatic Cancer
- Interventions
- Radiation: Hypofractionated Ablative Proton Therapy
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 24
- Registration Number
- NCT03652428
- Locations
- 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸University of Maryland Medical Center/Maryland Proton Treatment Center, Baltimore, Maryland, United States
SEEK: Dissemination and Implementation
- Conditions
- Child Maltreatment
- Interventions
- Other: Independent online training (IND)
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 1100
- Registration Number
- NCT03642327
- Locations
- 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
Pharmacokinetics of Antiepileptics in Patients on CRRT
- Conditions
- Acute Kidney InjuryRenal InsufficiencyRenal FailurePharmacokinetics
- Interventions
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 18
- Registration Number
- NCT03632915
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT03631654
Prebiotic Treatment in People With Schizophrenia - Pilot Study
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Drug: PlaceboDrug: Prebiotin
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 26
- Registration Number
- NCT03617783
- Locations
- 🇺🇸
Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP), Catonsville, Maryland, United States